Meta Pixel

News and Announcements

Launch of the ResiFund sees it on track to deliver 10%+ return in year one and significantly outperform the market

  • Published December 16, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Key Takeaways:

Launch of the first Residential property fund of its kind, offering a superior way to invest in residential property and access to properties not available to most wholesale investors

This year saw the launch of the ResiFund, providing a unique and highly professional way to invest in residential property. Our recent acquisitions in Melbourne and Brisbane are on target for 20-30% equity uplifts + income returns of 6-7.5%.

Channel 7 coverage of the launch of the Australian Residential Property Fund (ResiFund)

 

About OpenCorp

Open Corp are arguably Australia’s most qualified and successful residential investment group, having acquired over 1,000 properties in the last 10 years (with an average return of 10.8% p.a- unleveraged), are currently managing over 900 properties and have been the manager for 25 property funds and joint ventures.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now